Skip to content

Ansorius

Active Private limited companyfounded 2024active for 2 yearsRue des Charmes 29, 6600 BastogneKBO/BCE: BE 1006.409.939

Overview

Lifetime

2 annual accounts with figures on one time axis
peak €126,894 (2025)
€126,894▲ 74.8%
peak €87,319 (2025)
€87,319▲ 105%
peak €131,956 (2025)
€131,956▲ 196%
€42,867▼ 3.4%
Board1 name since 2024
Documentsfilings and deeds
16-06-202645 days before the deadline
2025micro format
Gross margin from €72,595 to €126,894Result from €42,637 to €87,319Equity from €44,637 to €131,956Cash from €31,962 to €117,148

Key points

from the 2025 annual accounts

Equity

€131,956 ▲ 196%
€44,6002024€132,0002025

Equity rose in 2025 from €44,637 to €131,956.

Liquidity

4.74 was 2.34 in 2024

Short-term debts rose from €20,402 to €28,980.

Position in the sector

€87,319

Higher net result than 95% of companies in retail trade. Sector median €5,052 · 22,922 companies.

Checked score

96
Excellent
Financially stronger than 95% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.6% across 40,277 companies (NACE 47, micro).

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 03-2025: 1.8% 04-2025: 1.8%● unchanged vs 03-2025 05-2025: 1.8%● unchanged vs 04-2025 06-2025: 2.2%▲ +0.4 percentage points vs 05-2025 07-2025: 2.3%▲ +0.1 percentage points vs 06-2025 08-2025: 2.6%▲ +0.3 percentage points vs 07-2025highest value 09-2025: 0.7%▼ -1.9 percentage points vs 08-2025 10-2025: 0.7%● unchanged vs 09-2025 11-2025: 0.7%● unchanged vs 10-2025 12-2025: 0.7%● unchanged vs 11-2025 01-2026: 0.7%● unchanged vs 12-2025 02-2026: 0.7%● unchanged vs 01-2026 03-2026: 0.8%▲ +0.1 percentage points vs 02-2026 04-2026: 0.8%● unchanged vs 03-2026 05-2026: 0.8%● unchanged vs 04-2026 06-2026: 0.8%● unchanged vs 05-2026 07-2026: 0.2%▼ -0.6 percentage points vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.1%▼ -0.1 percentage points vs 09-2026lowest value 11-2026: 0.1%● unchanged vs 10-2026lowest value

Financial strength
Strong

100+25equity 75.5% of total assets
96+9short-term debt 16.6% · cash 67.0%
100=return on assets 49.9%

Score breakdown

raises risk
Founded in 2024
Sector: Retail trade (NACE 47)
lowers risk
Liquidity: current ratio 4.74, cash €117,148
Equity €131,956 (75.5% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 95% on liquidity, 96% on profitability and 96% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 39,278 companies had the same profile as Ansorius has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of Ansorius itself is lower: 0.1% within 12 months. It rests on far more data about Ansorius than the profile alone.

Test of the method

The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for Ansorius. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €12,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record

Liquidity is ample, with a current ratio of 4.74 (2.34 in 2024), above the usual 1.5. Short-term debt is 16.6% and cash 67% of total assets. 24.5% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 4.74, cash €117,148
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €131,956 (75.5% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-06-2026, 45 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
45 days early
2024
19 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 13 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Board and ownership

  • VILAIN Maxime Joseph Léon Hubert 100 sharesdeed of 28-02-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1006409939
Incorporation Founding capital of €2,000, 100 shares · Founder: VILAIN Maxime Joseph Léon Hubert · Appointment: VILAIN Maxime Joseph Léon Hubert (director) · published on 28-02-2024 · Gazette deed
First establishment Rue des Charmes 29, Bastogne
All 7 events

Comparable companies

same main activity, similar in size and age
Company
Ansorius Bastogne €174,823 €126,894 75.5% -
MANAGEMENT CONSULTING PHARMA Perwez €155,710 €130,455 67.6% -
Pharmacie Armée Britannique Forest €158,501 €116,864 -8.2% 1.5
RS PHARMA Berchem-Sainte-Agathe €201,141 €121,827 14.0% -
D-PHARMA Brasschaat €226,463 €111,763 86.1% -
Rougeardent SRL Liège €242,680 €125,459 68.3% -
HEYDE PHARMA Jabbeke €192,810 €180,701 64.6% -

These companies have the same main activity as Ansorius: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €156,000 and €243,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 26-02-2024Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 5 others
Establishment unit
2.356.704.3776600 Bastogne, since 26-02-2024
Financial year end
31 December
Peppol
Reachable since 23-07-2025
Company details

Annual accounts 2025

€126,894▲ 74.8%
≈ €380,000estimated
€87,319▲ 105%
€131,956▲ 196%
€174,823▲ 96.4%
Filing
Filed on 16-06-2026, 45 days before the end of the filing period
Financials

Insights on Ansorius

Ansorius has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €131,956 and a net result of €87,319.

Its solvency ranks better than 85% of 22,939 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 16-06-2026, 45 days before the deadline
€126,894
▲ 74.8%
€111,123
▲ 86.6%
€87,319
▲ 105%
€108,350
▲ 297%
75.5%
▲ 25.3 percentage points
4.74
▲ 2.40

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €380,000. Estimated: probably between €270,000 and €720,000.

Balance sheet

balance sheet total €174,823 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

75.5%

Higher than 85% of 22,939 companies in 2025.

4.74

Higher than 86% of 22,068 companies in 2025.

49.9%

Higher than 95% of 22,218 companies in 2025.

Ansorius Middle half of the sector 80% of the sector Micro accounts in retail trade (NACE 47)

Net result: top quarter · Equity: top quarter · Balance sheet total: middle half · Working capital: top quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024
Balance sheet: assets
20/58 174,82389,016
21/28 37,49341,296
22/27 37,49341,296
23 7,2362,449
24 4,6701,630
25 25,58737,217
29/58 137,33047,720
40/41 19,29615,758
40 19,29615,758
54/58 117,14831,962
490/1 886-
Balance sheet: equity and liabilities
10/49 174,82389,016
10/15 131,95644,637
10/11 2,0002,000
13 42,00042,000
133 42,00042,000
14 87,956637
17/49 42,86744,378
17 13,88723,508
170/4 13,88723,508
42/48 28,98020,402
42 9,6219,621
44 3,843343
440/4 3,843343
45 15,51610,439
450/3 15,51610,439
492/3 -468
Income statement
9900 126,89472,595
630 15,27112,485
640/8 501547
9901 111,12359,563
75/76B 7-
75 7-
65/66B 72590
65 72590
9903 111,05758,972
67/77 23,73916,335
9904 87,31942,637
9905 87,31942,637
Appropriation of the result
9906 87,95642,637
14P 637-
691/2 -42,000
6921 -42,000
Document PDFPDF

The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 16-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 16-06-2026 2026-00169879 PDF
31-12-2024 micro format 19-08-2025 2025-00387430 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024
126,39372,048
102,58955,123
11,46851,575
85,186-
108,35027,317
75.5%50.1%
4.742.34
0.320.99
66.2%95.5%
49.9%47.9%
over 100over 100

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024
Tangible fixed assets€11,468€51,575
€15,271€12,485

Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)

Insights on Ansorius

The operating result for 2025 is 87% higher than in 2024.

Debt's share of the balance-sheet total falls from 49.9% to 24.5%. Equity is higher and debt is lower.

Board & ownership

Board

1 director, since incorporation
Director
appointed by deed of 28-02-2024 term without a fixed end
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 12. Pouvoirs de l’organe d’administration S’il n’y a qu’un seul administrateur, la totalité des pouvoirs d’administration lui est…”
deed of 28-02-2024

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
Board
Mandates as a list
  • VILAIN Maxime Joseph Léon Hubert
    • Director, appointed by deed of 28-02-2024, still in office

See the board, name and registered office on a given date →

Control

This company
Ansorius
Equity €131,956
Profit €87,319 in 2025

Capital

Contribution
€2,000
Shares
100
Contribution per share
€20
Equity per share
€1,320 in 2025
Source
deed of 28-02-2024

Articles of association

deed of 28-02-2024 (in French)
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitié à charge de chaque partie pour procédure et expertise, intérêt légal en cours à la date du refus”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of May

Shareholders

At incorporation deed of 28-02-2024 ↗

Network & group

No group

Ansorius has no parent and no holdings in its annual accounts. VILAIN Maxime Joseph Léon Hubert is the only director. Ansorius shares no director with another company.

Timeline

Timeline

7 events since 2024

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBmicro format · 45 days before the deadline
2025
Liquidity doubles current ratio 4.74 The current ratio rises from 2.34 to 4.74.
Equity above €100,000 equity €131,956 ▲196% With a profit in every financial year since 2024, equity grows to €131,956.
Annual accounts 2024 filed PDFmicro format · 19 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:1006409939
2024
IncorporationFounding capital of €2,000, 100 shares · Founder: VILAIN Maxime Joseph Léon Hubert · Appointment: VILAIN Maxime Joseph Léon Hubert (director) · published on 28-02-20245 points ▸

Open the deed in the Belgian Official Gazette

First establishment Rue des Charmes 29, Bastogne

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

Ansorius was incorporated on 26 February 2024 as a private limited company by one natural person, with a starting capital of €2,000.12 VILAIN Maxime Joseph Léon Hubert is director of the company, appointed by deed of 28-02-2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 28-02-2024
  3. 3National Bank, annual accounts 2025

Company details

Identity

Enterprise number
1006.409.939
VAT number
BE 1006.409.939
Peppol ID
0208:1006409939
Legal form
Private limited company
Status
Active, normal situation
Founded
26-02-2024
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of May
deed of 28-02-2024 (in French)
Peppol
Reachable since 23-07-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
Ansorius in French
Entity type
Legal entity

Activities

NACEBEL 2025
Codes under NACEBEL 2008
47730 Retail trade main activity
21100 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209 Manufacture of basic pharmaceutical products and pharmaceutical preparations
68201 Real estate activities
70220 Business consulting
82990 Other business support services
PurposeThe purpose describes the activities the company may carry out under its articles.
“Les prestations et les remplacements de titulaires pharmaceutiques; Le soutien aux entreprises; Les prestations immobilières diverses; Les…”
7 activities
  1. Les prestations et les remplacements de titulaires pharmaceutiques ;
  2. Le soutien aux entreprises ;
  3. Les prestations immobilières diverses ;
  4. Les conseils opérationnels et financiers ;
  5. L’exploitation d’une officine pharmaceutique, avec ou sans fabrication et de laboratoires d’analyse ainsi que le commerce, dans son sens le plus large, de produits chimiques, pharmaceutiques et diététiques, de produits phytopharmaceutiques et vétérinaires, d’optique, articles de droguerie et d’herboristerie, de parfumerie, d’hygiène et d’entretien, d’appareils, instruments et accessoires de chirurgie, d’acoustique et d’orthopédie, bandages, systèmes d’alarme et autres produits ou objets s’y rapportant d’une façon quelconque ou pouvant y être adjoints utilement.
  6. La fabrication ainsi que la vente en gros et au détail de produits chimiques, pharmaceutiques, parapharmaceutiques et phytopharmaceutiques ainsi que de tous articles de parfumerie et de bandagisterie ;
  7. Les activités pour la santé humaine n.c.a. ;
deed of 28-02-2024 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Rue des Charmes 29 registered office 6600 Bastogne 26-02-2024 2.356.704.377

Buildings and parcels at the address

Ground area
803 m²

Location

registered office establishment The establishment unit on the map

Parcels

Cadastral parcelArea Buildings Height / floors
82302C1014/00T002803 m² - -

Contact

E-mail maxime.vilain@ansorius.com
Phone +32 476 62 92 33